Register for a live broadcast to learn more about TRODELVY (sacituzumab govitecan-hziy) with Dr. Hope S. Rugo

<< View All Contributors
Deborah (Debi) A. Boyle MSN, RN, AOCNS, FAAN, is editor in chief of Oncology Nursing News®. She is a long tenured oncology clinical nurse specialist who has practiced in both Comprehensive Cancer Centers and community cancer programs. A frequent speaker nationally and abroad, Debi is the recipient of numerous honors and has published more than 330 articles, chapters, monographs, editorials, blogs, and books. A writer, editor, and speaker, Debi is dedicated to advancing quality nursing education and practice within cancer care.

The Over-the-Counter Drug Conundrum

It is imperative for oncology nurses to know about all the drugs and supplements that their patients are taking.
PUBLISHED: 3:30 PM, MON JULY 1, 2019
Having a longstanding interest in cancer in the elderly, I have maintained a keen eye on the literature focusing on polypharmacy, since older adults are most at risk for this phenomenon. Case in point, for each chronic illness, a drug—or maybe 2 or more – is usually prescribed. Thus, when an older adult is subsequently diagnosed with cancer, they may already routinely be taking 4 to 6 medications for conditions such as hypertension, diabetes, arthritis pain, or coronary artery disease. This then is compounded by the addition of cancer-related medications which may include oral antineoplastics, drugs to manage adverse events, and other supportive care drugs. The number can grow even higher as many patients do not tell us when they are taking over-the-counter drugs or herbs and botanicals.

Many years ago, I heard a geriatrician speak on elder pharmacologic issues. He offered some advice that, for me, prevails to this day. He cautioned, “Every time you see an older person have an unusual symptom experience, namely an exaggerated presentation, or an unexplained response to a medication, consider the possibility that the patient is consuming over the counter (OTC) drugs that they have not told you about.”

In a quality improvement project I spearheaded years ago on delirium in older hospitalized patients with cancer, I realized the prominence of this phenomenon.

Family members of patients who were admitted to the oncology unit with delirium were questioned about what the patient had been taking at home before their admission. In almost all instances, the patients were self-medicating themselves with OTC drugs having anticholinergic effects known to cause cognitive impairment in the elderly. Additionally, the average number of drugs they were consuming was 12 daily.

The majority of Americans who use OTC drugs are over age 65.1 Additionally, it is estimated that one-thirds of patients with cancer take some type of supplement.2 Unknown to the lay consumer is the fact that just because these drugs can be purchased without a prescription, does not mean they are without deleterious effects.

Dietary supplements and OTC medications may have pharmacologic effects similar to prescription drugs. When taken together, there is the possibility that increased adverse events may occur. For example, when taking a prescription medication for sleep or anxiety in addition to supplements such as chamomile, kava, lavender, or valerian, increased drowsiness or sedation may result. This might be observed in an older patient with lymphoma complaining of difficulty sleeping. After being prescribed a hypnotic at bedtime, the patient then can have difficulty becoming aroused in the morning. Also, supplements taken for a non-cancer condition may have deleterious effects on the patient’s physical status. A good example of this is when patients take chondroitin, glucosamine, or turmeric for osteoarthritis. These supplements can have antiplatelet and anticoagulant properties which increase the patient’s risk for bleeding.

In meeting with newly diagnosed patients, it is imperative that they are given the message that the treatment team needs to know about all prescription and non-prescription drugs and supplements they are consuming. One approach is the “Brown Bag” request, asking new patients to bring all drugs and supplements they are consuming for a medical condition at the start of treatment.

An excellent resource I have found for nurses and patients is the website www.mskcc.aboutbotanicals/herbs where one can search information about non-prescription supplements inclusive of their potential interactions with prescription medications and research findings about their efficacy. I strongly suggest that this evidence-based resource be made available to all our patients.

1. Qato DM, Alexander DC, Conti RM Use of prescription and over the counter medications and dietary supplements among older adults in the United States. JAMA, 2008 300(24): 2867-2878.

2. Farina EK, Austin KG, Lieberman HR. Concomitant dietary supplement and prescription medication use is prevalent in US adults with doctor-informed medical conditions. J Acad Nutr Diet, 2014. 114: 1784-1790.

Talk about this article with nurses and others in the oncology community in the General Discussions Oncology Nursing News discussion group.
More from Deborah (Debi) A. Boyle MSN, RN, AOCNS, FAAN
The stigma around palliative care is that it is only associated with end of life, and in some minds, giving up. But that isn't the case, as palliative care is a vital part of any critical care.  
PUBLISHED: Fri October 18 2019
Among the various specialties of nursing, a sort of hierarchy has formed that may be putting competency with machines over nurse and patient interactions.
PUBLISHED: Tue October 15 2019
The grieving process doesn't stop when you think you're ready to go back to work, and it can be made worse when your coworkers are unsure how to console you. Which is why workplace assistance is essential for grieving employees.   
PUBLISHED: Tue October 08 2019
A recent ranking of "the best" hospitals in the country did not take a key aspect of cancer care into proper consideration, the oncology nurse.
PUBLISHED: Wed September 25 2019
External Resources

MJH Associates
American Journal of Managed Care
MD Magazine
Pharmacy Times
Physicians' Education Resource
Specialty Pharmacy Times
OncNurse Resources

Continuing Education
Web Exclusives

About Us
Advisory Board
Contact Us
Privacy Policy
Terms & Conditions
Intellisphere, LLC
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 609-716-7777
F: 609-716-4747

Copyright OncNursing 2006-2019
Intellisphere, LLC. All Rights Reserved.